Brain and Central Nervous System Tumors Clinical Trials Database - Free Access to 288 Studies
Access comprehensive clinical trial information for Brain and Central Nervous System Tumors through Pure Global AI's free database. This collection includes 288 clinical trials across multiple phases including Phase 2, Phase 1, Early Phase 1. Currently, 4 trials are actively recruiting participants.
Research for Brain and Central Nervous System Tumors is being conducted in United States of America, Canada,United States of America, United Kingdom and 7+ other countries. Leading sponsors include Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Duke University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma
Studying Gene Expression and Location in Samples From Patients With Brain Tumors
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme
Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Study of Blood and Cheek Cell Samples From Patients With Glioma
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
Study of Tissue and Blood Samples From Patients With High-Grade Glioma
Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Pure Global AI provides free access to 288 clinical trials studying Brain and Central Nervous System Tumors, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Duke University, National Cancer Institute (NCI), among others.